Full details, including potential risk factors, are given in the Press Release, which can be consulted by clicking on the link below
Nicox Enters Research Collaboration with Re-Vana Therapeutics on its Next Generation of Stand-alone NO-donors in a Novel Sustained Release Ophthalmic Formulation

October 20, 2017

View Press Release Corporate presentation Contact us
Previous